Fungal Diversity

, Volume 55, Issue 1, pp 1–35 | Cite as

Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action

  • Dilani D. De Silva
  • Sylvie Rapior
  • Françoise Fons
  • Ali H. Bahkali
  • Kevin D. Hyde
Original Paper

Abstract

Medicinal mushrooms have been valued as natural sources of bioactive compounds since times immemorial and have been recognized as potential immunomodulating and anti-cancer agents. Their consumption has consistently been shown to have beneficial effects on human health. Cancer is a generic term for several types of diseases that can be chronic and are responsible for a large number of deaths worldwide. Although there has been considerable progress in modern cancer therapy research, difficulties in understanding the molecular behavior of various types of cancers and the numerous side effects experienced by patients from treatments means that this whole subject area is still problematic. Thus, biological immunotherapy using natural bioactive compounds as supportive treatments in conventional cancer therapies has become in vogue. Bioactive metabolites isolated from medicinal mushrooms have shown potential successes in cancer treatment as biological immunotherapeutic agents that stimulate the immune system against cancer cells. They also act as an effective source of anti-cancer agents, capable of interfering with cellular signal transduction pathways linked to cancer development and progression. In this review we compile available data on the characteristics of medicinal mushrooms that appear to be particularly effective as biological immunotherapeutic agents. Major consideration is given to biological constituents and the putative mechanisms of action by which bioactive compounds act on the human body. Consideration is also given to the benefits that have been claimed for the use of mushrooms in treating cancer and the future prospects of using medicinal mushrooms as potent supportive candidate bioagents for treatment of cancers is discussed.

Keywords

Medicinal mushrooms Cancer Anti-cancer Immunomodulation Bioactive metabolites 

References

  1. Abe Y, Miyake M, Horiuchi A, Kito K, Sagawa KS (1990) Induction of cytokines by polysaccharide K in the peripheral blood mononuclear cell culture. J Clin Exp Med (Tokyo) 152:617–618Google Scholar
  2. Abercrombie M, Ambrose EJ (1962) The surface properties of cancer cells: a review. Cancer Res 22:525–548PubMedGoogle Scholar
  3. Abraham WR (2001) Bioactive Sesquiterpenes produced by fungi: are they useful for humans as well? Curr Med Chem 8:583–606PubMedGoogle Scholar
  4. ACS (2011) American Cancer Society. Treatments and side effects http://www.cancer.org
  5. Ajith TA, Janaradhanan KK (2003) Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat. J Ethnopharmacol 84:157–162PubMedCrossRefGoogle Scholar
  6. Ajith TA, Janardhanan KK (2007) Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J Clin Biochem Nutr 40:157–162CrossRefGoogle Scholar
  7. Akihisa T, Uchiyama E, Kikuchi T, Tokuda H, Suzuki T, Kimura Y (2009) Anti-tumor-promoting effects of 25-Methoxyporicoic acid A and other triterpene acids from Poria cocos. J Nat Prod 72:1786–1792PubMedCrossRefGoogle Scholar
  8. Akiyama H, Endo M, Matsui T, Katsuda I, Emi N, Kawamoto Y, Koike T, Beppu H (2011) Agaritine from Agaricus blazei Murrill induces apoptosis in the leukemic cell line U937. Biochim Biophys Acta 1810:519–525PubMedCrossRefGoogle Scholar
  9. Alexandre J, Raymond E, Kaci MO, Brain EC, Lokiec FO et al (2004) Phase I and pharmacokinetic study of Irofulven administered weekly or biweekly in advanced solid tumor patients. Clin Cancer Res 10:3377–3385PubMedCrossRefGoogle Scholar
  10. Alexandre J, Kahatt C, Cvitkovic FB, Faivre S, Shibata S et al (2007) A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors. Invest New Drugs 25:453–462PubMedCrossRefGoogle Scholar
  11. Aly AH, Debbab A, Kjer J, Proksch P (2010) Fungal endophytes from higher plants: a prolific source of phytochemicals and other bioactive natural products. Fungal Divers 41:1–16CrossRefGoogle Scholar
  12. Aly AH, Debbab A, Proksch P (2011) Fifty years of drug discovery from fungi Review. Fungal Divers 50:3–19CrossRefGoogle Scholar
  13. Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharmaceut Res 25:2097–2116CrossRefGoogle Scholar
  14. Anon (2010) Council conclusions “Innovative approaches for chronic diseases in public health and healthcare systems”. Council of the European Union 3053rd Employment, Social policy health and consumer affairs council meeting Brussels, 7Google Scholar
  15. Anon (2011) Chemotherapy and cancer treatment, coping with side effects http://www.medicinenet.com/script/main/art.asp?articlekey=21716
  16. Anon (1999) Maitake Products Inc. Maitake D-fraction technical support document. Paramus, New JerseyGoogle Scholar
  17. Anon (2006) Ganoderma lucidum in cancer research. Leukemia Res 30:767–768CrossRefGoogle Scholar
  18. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R 3rd, Kumamoto T, Edelbaum D, Morita A, Bergstresser PR, Takashima A (2000) Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 275:20157–20167PubMedCrossRefGoogle Scholar
  19. Auerbach L (2006) Complementary and alternative medicine in the treatment of prostate cancer. J Men’s Health Gender Pract Med 3:397–403CrossRefGoogle Scholar
  20. Bao X, Duan J, Fang X, Fang J (2001a) Chemical modifications of the (1→3)-α-D-glucan from spores of Ganoderma lucidum and investigation of their physicochemical properties and immunological activity. Carbohyd Res 336:127–140CrossRefGoogle Scholar
  21. Bao XF, Liu CP, Fang JN, Li XY (2001b) Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohyd Res 322:67–74CrossRefGoogle Scholar
  22. Beaglehole R, Horton R (2010) Chronic diseases: global action must match global evidence. Lancet 376:1619–1621PubMedCrossRefGoogle Scholar
  23. Bezivin C, Delcros JG, Fortin H, Amoros M, Boustie J (2003) Toxicity and antitumor activity of a crude extract from Lepista inversa (Scop.:Fr.) Pat. (Agaricomycetideae): a preliminary study. Int J Med Mushr 5:25–30CrossRefGoogle Scholar
  24. Bin C (2010) Optimization of extraction of Tremella fuciformis polysaccharides and its antioxidant and antitumour activities in vitro. Carbohyd Polym 81:420–424CrossRefGoogle Scholar
  25. Blackwell M (2011) The fungi: 1, 2, 3 … 5.1 million species? Am J Bot 98(3):426–438PubMedCrossRefGoogle Scholar
  26. Boh B, Berivic M (2007) Grifola frondosa (Diks.:Fr.) S.F. Gray (Maitake mushroom): medicinal properties, active compounds, and biotechnological cultivation. Int J Med Mushr 9:89–108CrossRefGoogle Scholar
  27. Bohn JA, BeMiller JN (1995) β-(1→3)-D-glucan as biological response modifiers: a review of structure–functional activity relationships. Carbohyd Polym 28:3–14CrossRefGoogle Scholar
  28. Boonyanuphap J, Hansawasdi C (2010) Spatial distribution of β-glucan containing wild mushroom communities in subtropical dry forest, Thailand. Fungal Divers 46:29–42CrossRefGoogle Scholar
  29. Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME (1999) Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 221:281–293PubMedCrossRefGoogle Scholar
  30. Borchers AT, Keen CL, Gershwin ME (2004) Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 229:393–406Google Scholar
  31. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME (2008) The immunobiology of mushrooms. Exp Biol Med (Maywood) 233:259–276CrossRefGoogle Scholar
  32. Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6:33–43PubMedCrossRefGoogle Scholar
  33. Brown GD, Gordon S (2001) Immune recognition. A new receptor for β-glucans. Nature 413:36–37PubMedCrossRefGoogle Scholar
  34. Brown GD, Gordon S (2005) Immune recognition of fungal β-glucans. Cell Microbiol 7:471–479PubMedCrossRefGoogle Scholar
  35. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S (2002) Dectin-1 is a major β-glucan receptor on macrophages. J Exp Med 196:407–412PubMedCrossRefGoogle Scholar
  36. Campos Ziegenbein F, Hanssen HP, König WA (2006) Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus. Phytochemistry 67(2):202–211PubMedCrossRefGoogle Scholar
  37. CDC Centers for Disease control and prevention (2011) Chronic disease prevention and health promotion. Cancer addressing the cancer burden at a glance 2011 www.cdc.gov/nccdphp/publications/aag/dcpc.htm
  38. Chan GCF, Chan WK, Yuen Sze DM (2009) The effects of β-glucan on human immune and cancer cells. J Hematol Oncol 2:1–11CrossRefGoogle Scholar
  39. Chang ST (1999) Global impact of edible and medicinal mushrooms on human welfare in the 21st century: nongreen revolution. Int J Med Mushr 1:1–8Google Scholar
  40. Chang ST (2006) The need for scientific validation of culinary medicinal mushroom products. Int J Med Mushr 8:187–195CrossRefGoogle Scholar
  41. Chang ST, Buswell JA (2003) Medicinal mushrooms—a prominent source of nutriceuticals for the 21st century. Curr Trends Nutraceutical Res 1:257–280Google Scholar
  42. Chang ST, Miles PG (1992) Mushroom biology: a new discipline. Mycologist 6:64–73CrossRefGoogle Scholar
  43. Chang ST, Mshigeni KE (2000) Ganoderma lucidum—Paramount among medicinal mushrooms. Discov Innov 12:97–101Google Scholar
  44. Chang UM, Li CH, Lin LI, Huang CP, Kan LS, Lin SB (2006) Ganoderiol F, a Ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 79:1129–1139PubMedCrossRefGoogle Scholar
  45. Chen DH, Chen WKD (2003) Determination of ganoderic acids in triterpenoid constituents of Ganoderma tsugae. J Food Drug Anal 11:195–201Google Scholar
  46. Chen SJ, Jin SY (1992) Summary of research of hosts of Cordyceps sinensis in china. Shizhen Guoyao Yanju 3:37–39Google Scholar
  47. Chen J, Seviour R (2007) Medicinal importance of fungal β-(1#3), (1#6)-glucans. Mycol Res 111:635–652PubMedCrossRefGoogle Scholar
  48. Chen W, He FY, Li YQ (2006) The apoptosis effect of hispolon from Phellinus linteus (Berkeley & Curtis) Teng on human epidermoid κB cells. J Ethnopharmacol 105:280–285PubMedCrossRefGoogle Scholar
  49. Chen W, Zhao Z, Li L, Wu B, Chen SF, Zhou H, Wang Y, Li YQ (2008a) Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway. Free Radic Biol Med 45:60–72PubMedCrossRefGoogle Scholar
  50. Chen NH, Liu JW, Zhong JJ (2008b) Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J Pharmacol Sci 108:212–216PubMedCrossRefGoogle Scholar
  51. Chen JN, Yu Ma C, Tsai PF, Wang YT, Wu JS (2010a) In Vitro antitumor and immunomodulatory effects of the protein PCP-3A from mushroom Pleurotus citrinopileatus. J Agric Food Chem 58:12117–12122CrossRefGoogle Scholar
  52. Chen YC, Ho HO, Su CH, Sheu MT (2010b) Anticancer effects of Taiwanofungus camphoratus extracts, isolated compounds and its combinational use. J Exp Clin Med 2(6):274–281CrossRefGoogle Scholar
  53. Chen L, Pan J, Li X, Zhou Y, Meng Q, Wang Q (2011) Endo-polysaccharide of Phellinus igniarius exhibited anti-tumor effect through enhancement of cell mediated immunity. Int Immunopharmacol 11:255–259PubMedCrossRefGoogle Scholar
  54. Cheng CR, Yue QX, Wu ZY, Song XY, Tao SJ, Wu XH, Xu PP, Liu X, Guan SH, Guo DA (2010) Cytotoxic triterpenoids from Ganoderma lucidum. Phytochem 71:1579–1585CrossRefGoogle Scholar
  55. Cheung PC (2008) Mushrooms as functional food. Wiley, New YorkCrossRefGoogle Scholar
  56. Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F (1969) Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing. Nature 222:687–688PubMedCrossRefGoogle Scholar
  57. Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F (1970) Fractionation and purification of the polysaccharides with marked antitumour activity, especially lentinan, from Lentinus edodes (Berk.) Sing, an edible mushroom. Cancer Res 30:2776–2781PubMedGoogle Scholar
  58. Chin SK, Law CL, Cheng PG (2011) Effect of drying on crude ganoderic acids and water soluble polysaccharides content in Ganoderma lucidum. Int J Pharm Pharm Sci 3:38–43Google Scholar
  59. Chung MJ, Chung CK, Jeong Y, Ham SS (2010) Anti-cancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells. Nutr Res Pract 4(3):177–182PubMedCrossRefGoogle Scholar
  60. Clarke PA, Poele R, Wooster R, Workman P (2001) Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 62:1311–1336PubMedCrossRefGoogle Scholar
  61. Cui J, Chisti Y (2003) Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv 21:109–122PubMedCrossRefGoogle Scholar
  62. Dai YC (2010) Hymenochaetaceae (Basidiomycota) in China. Fungal Divers 45:131–343CrossRefGoogle Scholar
  63. Demleitner S, Kraus J, Franz G (1992) Synthesis and antitumour activity of derivatives of curdlan and lichenan branched at C-6. Carbohyd Res 226:239–246CrossRefGoogle Scholar
  64. Devereux S, Hatton MQF, Macbeth FR (1997) Immediate side effects of large fraction Radiotherapy. Clin Oncol 9:96–99CrossRefGoogle Scholar
  65. Didukh MY, Wasser SP, Nevo E (2003) Medicinal value of species of the family Agaricaceae Cohn (higher Basidiomycetes) current stage of knowledge and future perspectives. Int J Med Mushr 5:133–152CrossRefGoogle Scholar
  66. Ding ZH, Dong ZJ, Liu JK (2001) Albaconol, a novel prenylated resorcinol (=benzene-1,3-diol) from Basidiomycetes Albatrellus confluens. Helv Chim Acta 84:259–262CrossRefGoogle Scholar
  67. Dings RPM, Laar ESV, Webber J, Zhang Y, Griffin RJ et al (2008) Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven. Cancer Lett 265:270–280PubMedCrossRefGoogle Scholar
  68. Diniz SN, Nomizo R, Cisalpino PS, Teixeira MM, Brown GD, Mantovani A, Gordon S, Reis LF, Dias AA (2004) PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 75:649–656PubMedCrossRefGoogle Scholar
  69. Ehrke MJ (2003) Immunomodulation in cancer therapeutics. Int Immunopharmacol 3:1105–1119PubMedCrossRefGoogle Scholar
  70. Endo M, Beppu H, Akiyama H, Wakamatsu K, Ito S, Kawamoto Y, Shimpo K, Sumiya T, Koike T, Matsui T (2010) Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells. Biochim Biophys Acta 1800:669–673PubMedCrossRefGoogle Scholar
  71. Erkel G, Anke T (2008) Products from Basidiomycetes chapter 11. Biotechnology Set, 2nd edn. Wiley, New York, pp 490–526Google Scholar
  72. Erkel G, Anke T, Sterner O (1996) Inhibition of NF-κB activation by panepoxydone. Biochem Biophys Res Commun 226:214–221PubMedCrossRefGoogle Scholar
  73. Erkel G, Wisser G, Anke T (2007) Influence of the fungal NF-κB inhibitor panepoxydone on inflammatory gene expression in MonoMac6 cells. Int Immunopharmacol 7(5):612–624PubMedCrossRefGoogle Scholar
  74. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21–33PubMedCrossRefGoogle Scholar
  75. Feng L, HuaAn W, YongJie Z, Min A, XingZhong L (2011) Purification and characterization of a novel immunomodulatory protein from the medicinal mushroom Trametes versicolor. Sci China Life Sci 54:379–385CrossRefGoogle Scholar
  76. Ferreira ICFR, Vaz JA, Vasconcelos MH, Martins A (2010) Compounds from wild mushrooms with antitumor potential. Anticancer Agents Med Chem 10:424–436PubMedGoogle Scholar
  77. Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651–2660PubMedGoogle Scholar
  78. Firenzuoli F, Gori L, Lombardo G (2008) The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evid Based Complement Alternat Med 5:3–15PubMedCrossRefGoogle Scholar
  79. Fortin H, Tomasi S, Delcros JG, Bansard JY, Boustie J (2006) In vivo antitumor activity of Clitocine, an exocyclic amino nucleoside isolated from Lepista inversa. Chem Med Chem 1:189–196PubMedGoogle Scholar
  80. Francia C, Rapior S, Courtecuisse R, Siroux Y (1999) Current research findings on the effects of selected mushrooms on cardiovascular diseases. Int J Med Mushr 1:169–172Google Scholar
  81. Francia C, Fons F, Poucheret P, Rapior S (2007) Activités biologiques des champignons: utilisations en médecine traditionnelle. Annales de la Société d’Horticulture et d’Histoire Naturelle de l’Hérault 147:77–88Google Scholar
  82. Franks LM (1997) Prostatic cancer: future prospects for diagnosis and screening. Brit J Urol 79:107–108PubMedGoogle Scholar
  83. Fu H, Guo WY, Yin H, Wang ZX, Li RD (2011) Inhibition of Lentinus edodes polysaccharides against liver tumour growth. Int J Phys Sci 6:116–120Google Scholar
  84. Fujimoto K, Tomonaga M, Goto S (2006) A case of recurrent ovarian cancer successfully treated with adoptive immunotherapy and lentinan. Anticancer Res 26:4015–4018PubMedGoogle Scholar
  85. Furue H (1987) Biological characteristics and clinical effect of sizolilan (SPG). Med Actual 23:335–346Google Scholar
  86. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM (2003) Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J Exp Med 197:1107–1117PubMedCrossRefGoogle Scholar
  87. Gao QP, Seljelid R, Chen HQ, Jiang R (1996) Characterization of acidic heteroglycans from Tremella fuciformis Berk. with cytokine stimulating activity. Carbohyd Res 288:135–142CrossRefGoogle Scholar
  88. Gao Y, Zhou S, Jiang W, Huang M, Dai X (2003) Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32:201–215PubMedCrossRefGoogle Scholar
  89. Gao Y, Chan E, Zhou S (2004) Immunomodulating activities of Ganoderma, a mushroom with medicinal properties. Food Rev Int 20:123–161CrossRefGoogle Scholar
  90. Ge ZW, Yang ZL, Vellinga EC (2010) The genus Macrolepiota (Agaricaceae, Basidiomycota) in China. Fungal Divers 45:81–98CrossRefGoogle Scholar
  91. Gibbs JB (2000) Mechanism-based target identification and drug discovery in cancer research. Science 287:1969–1973PubMedCrossRefGoogle Scholar
  92. Girzal VU, Neelagund S, Krishnappa M (2011) Ganoderma lucidum: a source for novel bioactive lectin. Protein Peptide Lett 18:1150–1157CrossRefGoogle Scholar
  93. Gonindard C, Bergonzi C, Denier C, Sergheraert C, Klaebe A, Chavant L, Hollande E (1997) Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro. Cell Biol Toxicol 13:141–153PubMedCrossRefGoogle Scholar
  94. Gonzaga MLC, Bezerra DP, Alves APNN, Alencar NMN, Mesquita RO, Lima MW, Aguiar-Soares S, Pessoa C, Moraes MO, Costa-Lotufo LV (2009) In vivo growth-inhibition of Sarcoma 180 by an α-(1→4)-glucan-β-(1→6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill. J Nat Med 63:32–40PubMedCrossRefGoogle Scholar
  95. Griffin DH (1994) Fungal physiology, 2nd edn. Wiley-Lis, Inc., New YorkGoogle Scholar
  96. Grube BJ, Eng ET, Kao YC et al (2001) White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr 131:3288–3293PubMedGoogle Scholar
  97. Grunebach F, Weck MM, Reichert J, Brossart P (2002) Molecular and functional characterization of human dectin-1. Exp Hematol 30:1309–1315PubMedCrossRefGoogle Scholar
  98. Guillamón E, Lafuente AG, Lozano M, Arrigo MD, Rostagno MA, Villares A, Martínez JA (2010) Edible mushrooms: role in the prevention of cardiovascular diseases. Fitoterapia 81:715–723PubMedCrossRefGoogle Scholar
  99. Guo Z, Hu Y, Wang D, Ma X, Zhao X, Zhao B et al (2008) Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine. Vaccine 27:660–665PubMedCrossRefGoogle Scholar
  100. Guo L, Xie J, Ruan Y, Zhou L, Zhu H, Yun X, Jiang Y, Lü L, Chen K, Min Z, Wen Y, Gu J (2009) Characterization and immunostimulatory activity of a polysaccharide from the spores of Ganoderma lucidum. Int Immunopharmacol 9:1175–1182PubMedCrossRefGoogle Scholar
  101. Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID, Yang KH et al (1999) The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacol 41:157–164CrossRefGoogle Scholar
  102. Han HC, Lindequist U, Hyun JW, Kim YH, An HS, Lee DH et al (2004) Apoptosis induction by acetoxyscirpendiol from Paecilomyces tenuipes in human leukaemia cell lines. Pharmazie 59:42–49PubMedGoogle Scholar
  103. Han SB, Lee CW, Kang JS, Yoon YD, Lee KH, Lee K, Park SK, Kim HM (2006) Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion. Int Immunopharmacol 6:697–702PubMedCrossRefGoogle Scholar
  104. Harhaji LJ, Mijatovic S, Ivanic DM, Stojanovic I, Momcilovic M, Maksimovic V, Tufegdzic S, Marjanovic Z, Stojkovic MM, Vucinic Z, Grujicic ST (2008) Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: in vitro and in vivo study. Food Chem Toxicol 46:1825–1833PubMedCrossRefGoogle Scholar
  105. Hartley AJ, Mattos-Shipley K, Collins CM, Kilaru S, Foster GD, Bailey AM (2009) Investigating pleuromutilin-producing Clitopilus species and related basidiomycetes. Microbiol Lett 297:24–30CrossRefGoogle Scholar
  106. Hasegawa T, Fujisawa T, Haraguchi S, Numata M, Karinaga R, Kimura T, Okumura S, Sakurai K, Shinkai S (2005) Schizophyllan–folate conjugate as a new non-cytotoxic and cancer-targeted antisense carrier. Bioorg Med Chem Lett 15:327–330PubMedCrossRefGoogle Scholar
  107. Hattori TS, Komatsu N, Shichijo S, Itoh K (2004) Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa. Biomed Pharmacother 58:226–230PubMedCrossRefGoogle Scholar
  108. Hawksworth DL (2001) Mushrooms: the extent of the unexplored potential. Int J Med Mushr 3:333–337Google Scholar
  109. Hayakawa K, Mitsuhashi N, Saito Y, Takahashi M, Katano S, Shiojima K, Furuta M, Nibe H (1993) Effect of Krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non small cell lung cancer. Anticancer Res 13:1815–1820PubMedGoogle Scholar
  110. Heleno SA, Barros L, Sousa MJ, Martins A, Santos-Buelga C, Ferreira ICFR (2011) Targeted metabolites analysis in wild Boletus species. LWT - Food Sci Technol 44:1343–1348CrossRefGoogle Scholar
  111. Herre J, Gordon S, Brown GD (2004) Dectin-1 and its role in the recognition of β-glucans by macrophages. Mol Immunol 40:869–876PubMedCrossRefGoogle Scholar
  112. Herzig M, Trevino AV, Liang H, Salinas R, Waters S, MacDonald JR, Woynarowska B, Woynarowski J (2003) Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent. Biochem Pharmacol 65:503–513PubMedCrossRefGoogle Scholar
  113. Hilgers W, Faivre S, Chieze S, Alexandre J, Lokiec F et al (2006) A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors. Invest New Drugs 24:311–319PubMedCrossRefGoogle Scholar
  114. Hirata Y, Nahanishi K (1950) Grifolin, an antibiotic from a Basidiomycete. J Biol Chem 184:135–144PubMedGoogle Scholar
  115. Hobbs C (1995) Medicinal mushrooms: an exploration of tradition, healing, and culture. Botanica Press, Santa Cruz, 251pGoogle Scholar
  116. Hobbs C (2000) Medicinal value of Lentinus edodes (Berk.) Sing. (Agaricomycetideae). A literature review. Int J Med Mushr 2:287–302Google Scholar
  117. Hobbs CR (2004) Medicinal value of Turkey Tail fungus Trametes versicolor (L.:Fr.) Pilát (Aphyllophoromycetideae). Int J Med Mushr 6:195–218CrossRefGoogle Scholar
  118. Hobbs CR (2005) The chemistry, nutritional value, immunopharmacology, and safety of the traditional food of medicinal split-gill fungus Schizophyllum commune Fr.:Fr. (Aphyllophoromycetideae). A literature review. Int J Med Mushr 7:127–140CrossRefGoogle Scholar
  119. Holliday H, Cleaver M (2008) Medicinal value of the caterpillar fungi species of the genus Cordyceps (Fr.) Link (Ascomycetes). Int J Med Mushr 10:209–218CrossRefGoogle Scholar
  120. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD (2004) Mechanism by which orally administered β-(1→3)-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173:797–806PubMedGoogle Scholar
  121. Hou XJ, Chen W (2008) Optimization of extraction process of crude polysaccharides from wild edible BaChu mushroom by response surface methodology. Carbohyd Polym 72:67–74CrossRefGoogle Scholar
  122. Hsiao YM, Huang YL, Tang SC, Shieh GJ, Lai JY, Wang PH, Ying TH, Ko JL (2008) Effect of a fungal immunomodulatory protein from Ganoderma tsugae on cell cycle and interferon-gamma production through phosphatidylinositol 3-kinase signal pathway. Process Biochem 43:423–430CrossRefGoogle Scholar
  123. Hsu CL, Yu YS, Yen GC (2008) Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway. J Agric Food Chem 56:3973–3980PubMedCrossRefGoogle Scholar
  124. Huang GJ, Yang CM, Chang YS, Amagaya S, Wang HC, Hou WC, Huang SS, Hu ML (2010) Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways. J Agric Food Chem 58(17):9468–9475PubMedCrossRefGoogle Scholar
  125. Huang HY, Chieh SY, Tso TK, Chien TY, Lin HT, Tsai YC (2011) Orally administered mycelial culture of Phellinus linteus exhibits antitumor effects in hepatoma cell-bearing mice. J Ethnopharmacol 133:460–466PubMedCrossRefGoogle Scholar
  126. Hung WT, Wang SH, Chen CH, Yang WB (2008) Structure determination of β-Glucans from Ganoderma lucidum with matrix-assisted laser desorption/ionization (MALDI) Mass Spectrometry. Molecules 13:1538–1550PubMedCrossRefGoogle Scholar
  127. Hyde KD (2001) Where are the missing fungi; Does Hong Kong have any answers. Mycol Res 105:1514–1518CrossRefGoogle Scholar
  128. Hyde KD, Bahkali AH, Moslem MA (2010) Fungi—an unusual source for cosmetics. Fungal Divers 43:1–9CrossRefGoogle Scholar
  129. Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S (2005) Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 23:2645–2654PubMedCrossRefGoogle Scholar
  130. Inoue M, Tanaka Y, Sugita N, Yamasaki M, Yamanaka T, Minagawa J, Nakamuro K, Tani T, Okudaira Y, Karita T et al (1993) Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy 6:13–18PubMedCrossRefGoogle Scholar
  131. Inoue A, Kodama N, Nanba H (2002) Effect of Maitake (Grifola frondosa) D-fraction on the control of the T lymphocyte node Th-1/Th-2 proportion. Biol Pharm Bull 25:536–540PubMedCrossRefGoogle Scholar
  132. Isaac S (1997) Fungi naturally form many diverse biochemical products, some of which are now commercially important; how and why do they do this? Mycol Answers 11:182–183Google Scholar
  133. Ishii PL, Prado CK, Mauro MO, Carreira CM, Mantovani MS, Ribeiro LR, Dichi JB, Oliveira RJ (2011) Evaluation of Agaricus blazei in vivo for antigenotoxic, anticarcinogenic, phagocytic and immunomodulatory activities. Regul Toxicol Pharmacol 59:412–422PubMedCrossRefGoogle Scholar
  134. Ivanković S, Hirsl N, Jakopovich I, Jurin M (2004) Influence of medicinal mushroom preparations on mouse tumors. Int J Med Mushr 6:107–116CrossRefGoogle Scholar
  135. Jakopovich I (2011) New dietary supplements from medicinal mushrooms: Dr Myko San—a registration report. Int J Med Mushr 13:307–313CrossRefGoogle Scholar
  136. Jang KJ, Han MH, Lee BH, Kim BW, Kim CH, Yoon HM, Choi YH (2010) Induction of apoptosis by ethanol extracts of Ganoderma lucidum in human gastric carcinoma cells. J Acupunct Meridian Stud 3:24–31PubMedCrossRefGoogle Scholar
  137. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. Cancer J Clinicians 59:225–249CrossRefGoogle Scholar
  138. Jeon T, Hwang SG, Jung YH, Yang HS, Sung NY, Lee J, Park DK, Yoo YC (2011) Inhibitory effect of oral administration of sangwhang mushroom (Phellinus linteus) grown on germinated brown rice on experimental lung metastasis and tumor growth in mice. Food Sci Biotechnol 20:209–214CrossRefGoogle Scholar
  139. Jeong JW, Jin CY, Park C, Hong SH, Kim GY, Jeong YK, Lee JD, Yoo YH, Choi YH (2011) Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells. Toxicol In Vitro 25:817–824PubMedCrossRefGoogle Scholar
  140. Jiang J, Silva D (2010) Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncology 37:1529–1536Google Scholar
  141. Jikai L (2002) Biologically active substances from mushrooms in Yunnan, China. Heterocycles 57:157–167CrossRefGoogle Scholar
  142. Jiménez-Medina E, Berruguilla E, Romero I, Algarra I, Collado A, Garrido F, Garcia-Lora A (2008) The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. Bio Med Central Cancer 8:78Google Scholar
  143. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683–692PubMedCrossRefGoogle Scholar
  144. Jong SC, Birmingham JM, Pai SH (1991) Immunomodulatory substances of fungal origin. J Immun Immunopharmacol 11:115–122Google Scholar
  145. Kakimi K, Nakajima J, Wada H (2009) Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer. Lung Cancer 65:1–8PubMedCrossRefGoogle Scholar
  146. Katano M, Yamamoto Y, Torisu M (1987) A suppressive effect of PSK, protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility. Jpn J Cancer Chemother 14:2321–2326Google Scholar
  147. Kawagishi H, Inagaki R, Kanao T, Mizuno T, Shimura K, Ito H, Hagiwara T, Hakamura T (1989) Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohyd Res 186:267–274CrossRefGoogle Scholar
  148. Kelner MJ, McMorris TC, Rojas RJ, Estes LA, Suthipinijtham P (2008) Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model. Cancer Chemother Pharm 63:19–26CrossRefGoogle Scholar
  149. Kerrigan R (2005) Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms. Mycologia 97:12–24PubMedCrossRefGoogle Scholar
  150. Khan MA, Tania M, Zhang DZ, Chen HC (2010) Cordyceps Mushroom: a potent anticancer nutraceutical. Open Nutraceuticals J 3:179–183CrossRefGoogle Scholar
  151. Kidd PM (2000) The use of mushroom Glucans and proteoglycans in cancer treatment. Altern Med Rev 5:4–27PubMedGoogle Scholar
  152. Kim HM, Han SB, Oh GT, Kim YH, Hong DH, Hongt ND, Yoo ID (1996) Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus. Int J Immunopharmacol 18:295–303PubMedCrossRefGoogle Scholar
  153. Kim GY, Park HS, Nam BH, Lee SJ, Lee JD (2003a) Purification and characterization of acidic proteo-heteroglycan from the fruiting body of Phellinus linteus (Berk & M.A. Curtis) Teng. Bioresource Technol 89:81–87CrossRefGoogle Scholar
  154. Kim GY, Park SK, Lee MK, Lee SH, Oh YH, Yoon S, Lee JD, Park YM (2003b) Proteoglycan isolated from Phellinus linteus activates murine B lymphocytes via protein kinase C and protein tyrosine kinase. Int Immunopharmacol 3:1281–1292PubMedCrossRefGoogle Scholar
  155. Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS (2006) Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci 79:72–80PubMedCrossRefGoogle Scholar
  156. Kim HG, Yoon DH, Lee WH, Han SK, Shrestha B, Kim CH, Lim MH, Chang W, Lim S, Choi S, Song WO, Sung JM, Hwang KC, Kim TW (2007) Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-κB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage. J Ethnopharmacol 114:307–315PubMedCrossRefGoogle Scholar
  157. Kim YS, Im J, Choi JN, Kang SS, Lee YJ, Lee CH, Yun CH, Son CG, Han SH (2010) Induction of ICAM-1 by Armillariella mellea is mediated through generation of reactive oxygen species and JNK activation. J Ethnopharmacol 128:198–205PubMedCrossRefGoogle Scholar
  158. Kim SP, Kang MY, Kim JH, Nam SH, Friedman M (2011) Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice. J Agric Food Chem 59(18):9861–9869PubMedGoogle Scholar
  159. Kimura Y, Tojima H, Fukase S et al (1994) Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta Otolaryngol 511:192–195CrossRefGoogle Scholar
  160. Kinge TR, Mih AM (2011) Secondary metabolites of oil palm isolates of Ganoderma zonatum Murill. from Cameroon and their cytotoxicity against five human tumour cell lines. Afr J Biotechnol 10(42):8440–8447Google Scholar
  161. Kino K, Yamashita A, Yamaoka K, Watanabe J, Tanaka S, Ko K et al (1989) Isolation and characterization of a new immunomodulatory protein, Ling Zhi-8 (LZ-8), from Ganoderma lucidum. J Biol Chem 264:472–478PubMedGoogle Scholar
  162. Kitamura S, Hori T, Kurita K, Takeo K, Hara C, Itoh W et al (1994) Antitumor, branched β-(1→3)-D-glucan from a water extract fruiting bodies of Cryptoporous volvatus. Carbohyd Res 26:111–121CrossRefGoogle Scholar
  163. Kleinwächter P, Anh N, Kiet TT, Schlegel B, Dahse HM, Härtl A, Gräfe U (2001) Colossolactones, new triterpenoid metabolites from a Vietnamese mushroom Ganoderma colossum. J Nat Prod 64:236–239PubMedCrossRefGoogle Scholar
  164. Knudsen KE, Jensen BB, Hansen I (1993) Digestion of polysaccharides and other major components in the small and large intestine of pigs fed on diets consisting of oat fractions rich in β-D-glucan. Brit J Nutr 70:537–556PubMedCrossRefGoogle Scholar
  165. Ko JL, Hsu CI, Lin RH, Jai CL, Lin JY (1995) A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. Eur J Biochem 228:244–249PubMedCrossRefGoogle Scholar
  166. Kobayashi H, Matsunaga K, Oguchi Y (1995) Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev 4:275–281PubMedGoogle Scholar
  167. Kodama N, Harada N, Nanba H (2002a) A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 90:357–360PubMedCrossRefGoogle Scholar
  168. Kodama N, Komuta K, Nanba H (2002b) Can Maitake MD-fraction aid cancer patients? Altern Med Rev 7:236–239PubMedGoogle Scholar
  169. Kodama N, Murata Y, Asakawa A, Inui A, Hayashi M, Sakai N, Nanba H (2005) Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition 21:624–629PubMedCrossRefGoogle Scholar
  170. Kodama N, Mizuno S, Nanba H, Saito N (2010) Potential antitumor activity of a low-molecular weight protein fraction from Grifola frondosa through enhancement of cytokine production. J Med Food 13:20–30PubMedCrossRefGoogle Scholar
  171. Konno S (2001) Maitake D-fraction: apoptosis inducer and immune enhancer. Altern Complementary Ther 17:102–107CrossRefGoogle Scholar
  172. Krzyczkowski W, Malinowska E, Suchocki P, Kleps J, Olejnik M, Herold F (2009) Isolation and quantitative determination of ergosterol peroxide in various edible mushroom species. Food Chem 113:351–355CrossRefGoogle Scholar
  173. Kudugunti SK, Vad NM, Whiteside AJ, Naik BU, Yusuf MA, Srivenugopal KS, Moridani MY (2010) Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines. Chemico-Biol Interact 188:1–14CrossRefGoogle Scholar
  174. Kumar A, Takada Y, Boriek AM, Aggarwal BB (2004) Nuclear factor-κB: its role in health and disease. J Mol Med 82:434–448PubMedCrossRefGoogle Scholar
  175. Kumar RJ, Barqawi A, Crawford EA (2005) Adverse events associated with hormonal therapy for prostate cancer. Rev Urol 7:S37–S43PubMedGoogle Scholar
  176. Kuo MC, Weng CY, Ha CL, Wu MJ (2006) Ganoderma lucidum mycelia enhance innate immunity by activating NF-κB. J Ethnopharmacol 103:217–222PubMedCrossRefGoogle Scholar
  177. Kurashige S, Akuzawa Y, Endo F (1997) Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol Immunotoxicol 19:175–183PubMedCrossRefGoogle Scholar
  178. Ladanyi A, Timar J, Lapis K (1993) Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol Immunother 36:123–126PubMedCrossRefGoogle Scholar
  179. Lam SK, Ng TB (2001) Hypsin, a novel thermostable ribosome inactivating protein with antifungal and antipoliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. Biochem Biophys Res Commun 285:1071–1075PubMedCrossRefGoogle Scholar
  180. Lam YW, Ng TB, Wang HX (2001) Antipoliferative and antimitogenic activities in a peptide from puffball mushroom Calvatia caelata. Biochem Biophys Res Commun 289:744–749PubMedCrossRefGoogle Scholar
  181. Lee JS, Hong EK (2010) Hericium erinaceus enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells. Cancer Lett 297:144–154PubMedCrossRefGoogle Scholar
  182. Lee JS, Hong EK (2011) Immunostimulating activity of the polysaccharides isolated from Cordyceps militaris. Int Immunopharmacol 11:1226–1233PubMedCrossRefGoogle Scholar
  183. Lee IK, Yun BS (2007) Highly oxygenated and unsaturated metabolites providing a diversity of hispidin class antioxidants in the medicinal mushrooms Inonotus and Phellinus. Bioorgan Med Chem 15:3309–3314CrossRefGoogle Scholar
  184. Lee IK, Yun BS (2011) Styrylpyrone-class compounds from medicinal fungi Phellinus and Inonotus spp., and their medicinal Importance. J Antibiot 64:349–359PubMedCrossRefGoogle Scholar
  185. Lee WY, Park Y, Ahn JK, Ka KH, Park SY (2007a) Factors influencing the production of endopolysaccharide and exopolysaccharide from Ganoderma applanatum. Enzyme Microb Tech 40:249–254CrossRefGoogle Scholar
  186. Lee IK, Kim YS, Jang YW, Jung JY, Yun BS (2007b) New antioxidant polyphenols from the medicinal mushroom Inonotus obliquus. Bioorg Med Chem Lett 17(24):6678–6681PubMedCrossRefGoogle Scholar
  187. Lee YS, Kim YH, Shin EK, Kim DH, Lim SS, Lee JY, Kim JK (2010) Anti-angiogenic activity of methanol extract of Phellinus linteus and its fractions. J Ethnopharmacol 131:56–62PubMedCrossRefGoogle Scholar
  188. Leggas M, Stewart CF, Woo MH, Fouladi M, Cheshre PJ, Peterson JK, Friedman HS, Billups C, Houghton PJ (2002) Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts. Clin Cancer Res 8:3000–3007PubMedGoogle Scholar
  189. Lehmann VK, Huang A, Calero IS, Wilson GR, Rinehart KL (2003) Illudin S, the sole antiviral compound in mature fruiting bodies of Omphalotus illudens. J Nat Prod 66:1257–1258PubMedCrossRefGoogle Scholar
  190. Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, Abrahamsen TG (2006) Oral administration of a new soluble branched β-(1→3)-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin Exp Immunol 143:65–69PubMedCrossRefGoogle Scholar
  191. Lehtovaara BC, Gu FX (2011) Pharmacological, structural, and drug delivery properties and applications of β-(1→3)-glucans. J Agric Food Chem 59:6813–6828PubMedCrossRefGoogle Scholar
  192. Leung MYK, Liu C, Koon JCM, Fung KP (2006) Polysaccharide biological response modifiers. Immunol Lett 105:101–111PubMedCrossRefGoogle Scholar
  193. Li JWH, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier. Science 325:161–165PubMedCrossRefGoogle Scholar
  194. Li SP, Li P, Lai CM, Gong YX, Kan KKW, Dong TTX, Tsim KWK, Wang YT (2004) Simultaneous determination of ergosterol, nucleosides and their bases from natural and cultured Cordyceps by pressurized liquid extraction and high-performance liquid chromatography. J Chromatogr 1036:239–243CrossRefGoogle Scholar
  195. Li Q, Wang X, Chen Y, Lin J, Zhou X (2010a) Cytokines expression induced by Ganoderma sinensis fungal immunomodulatory proteins (FIP-gsi) in mouse spleen cells. Appl Biochem Biotechnol 162:1403–1413PubMedCrossRefGoogle Scholar
  196. Li YQ, Zhang BC, Wang XQ, Yan HD, Chen G, Zhang XW (2010b) Proteomic analysis of apoptosis induction in human lung cancer cells by recombinant MVL. Amino Acids 41(4):923–932. doi:10.1007/s00726-010-0791-0 PubMedCrossRefGoogle Scholar
  197. Li X, Xu W, Chen J (2010c) Polysaccharide purified from Polyporus umbellatus (Per) Fr induces the activation and maturation of murine bone-derived dendritic cells via toll-like receptor 4. Cell Immunol 265(1):50–56. doi:10.1016/j.cellimm.2010.07.002 PubMedCrossRefGoogle Scholar
  198. Li F, Wen H, Zhang Y, An M, Liu XZ (2011) Purification and characterization of a novel immunomodulatory protein from the medicinal mushroom Trametes versicolor. Sci China Life Sci 54:379–385PubMedCrossRefGoogle Scholar
  199. Liang H, Herzig M, Salinas R (2001) Pro-oxidative distortion of the cellular redox-homeostasis in irofulven-induced apoptosis. Clin Cancer Res 7:3723Google Scholar
  200. Lin Z-B (2009) Lingzhi. From mystery to science. Peking University Medical Press, Beijing, 162 pGoogle Scholar
  201. Lin YW, Chiang BH (2011) 4-Acetylantroquinonol B Isolated from Antrodia cinnamomea arrests proliferation of human hepatocellular carcinoma HepG2 cell by affecting p53, p21 and p27 Levels. J Agric Food Chem 59:8625–8631PubMedCrossRefGoogle Scholar
  202. Lin JT, Liu WH (2006) ο-Orsellinaldehyde from the submerged culture of the edible mushroom Grifola frondosa exhibits selective cytotoxic effect against Hep 3B cells through apoptosis. J Agric Food Chem 54:7564–7569PubMedCrossRefGoogle Scholar
  203. Lin SB, Li CH, Lee SS, Kan LS (2003) Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72:2381–2390PubMedCrossRefGoogle Scholar
  204. Lin Y, Lai P, Huang Y, Xie H (2004) Immune-competent polysacharides from the submerged cultured mycelium of culinary-medicinal mushroom Lentinus srigellus Berk. & Curt. (Agaricomycetideae). Int J Med Mushr 6:49–55CrossRefGoogle Scholar
  205. Lin YL, Liang YC, Tseng YS, Huang HY, Chou SY, Hseu RS et al (2009) An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-κB and MAPK pathways. J Leukoc Biol 86:877–889PubMedCrossRefGoogle Scholar
  206. Lin CH, Sheu GT, Lin YW, Yeh CS, Huang YH, Lai YC et al (2010) A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochem 45:1537–1542CrossRefGoogle Scholar
  207. Lin CC, Yu YL, Shih CC, Liu KJ, Ou KL, Hong LZ et al (2011) A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunol Immun 60:1019–1027Google Scholar
  208. Lindequist U, Niedermeyer THJ, Jülich WD (2005) The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2:285–299PubMedCrossRefGoogle Scholar
  209. Lindequist U, Rausch R, Füssel A, Hanssen HP (2010) Higher fungi in traditional and modern medicine. Med Monatsschr Pharm 33:40–48PubMedGoogle Scholar
  210. Liu J (2002) Biologically active substances from mushrooms in Yunnan, China. Heterocycles 57:157–167CrossRefGoogle Scholar
  211. Liu JJ, Huang TS, Hsu ML, Chen CC, Lin WS, Lu FJ, Chang WH (2004) Antitumor effects of the partially purified polysaccharides from Antrodia camphorata and the mechanism of its action. Toxicol Appl Pharmacol 201:186–193PubMedCrossRefGoogle Scholar
  212. Liu YW, Gao JL, Guan J, Qian ZM, Feng K, Li SP (2009a) Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. J Agric Food Chem 57:3087–3093PubMedCrossRefGoogle Scholar
  213. Liu K, Ding X, Deng B, Chen W (2009b) Isolation and characterization of endophytic taxol-producing fungi from Taxus chinensis. J Ind Microbiol Biotechnol 36:1171–1177PubMedCrossRefGoogle Scholar
  214. Liu J, Shimizu K, Kondo R (2010) The effects of ganoderma alcohols isolated from Ganoderma lucidum on the androgen receptor binding and the growth of LNCaP cells. Fitoterapia 81:1067–1072PubMedCrossRefGoogle Scholar
  215. Louie B, Rajamahanty S, Won J, Choudhury M, Konno S (2010) Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells. BJU Int 105:1011–1015PubMedCrossRefGoogle Scholar
  216. Lu TL, Huang GJ, Lu TJ, Wu JB, Wu CH, Yang TC, Iizuka A, Chen YF (2009) Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells. Food Chem Toxicol 47:2013–2021PubMedCrossRefGoogle Scholar
  217. Lull C, Wichers HJ, Savelkoul HFJ (2005) Antiinflammatory and immunomodulating properties of fungal metabolites. Mediat Inflamm 2:63–80CrossRefGoogle Scholar
  218. Luo X, Xu X, Yu M, Yang Z, Zheng L (2008) Characterisation and immunostimulatory activity of an α-(1→6)-D-glucan from the cultured Armillaria tabescens mycelia. Food Chem 111:357–363CrossRefGoogle Scholar
  219. Luo XJ, Li LL, Deng QP, Yu XF, Yang LF, Luo FJ, Xiao LB, Chen XY, Ye M, Liu JK, Cao Y (2011) Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells. Eur J Cancer 47(2):316–325PubMedCrossRefGoogle Scholar
  220. Maduro JH, Pras E, Willemse PHB, de Vries EGE (2003) Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 29:471–488PubMedCrossRefGoogle Scholar
  221. Mahajna J, Dotan N, Zaidman B-Z, Petrova RD, Wasser SP (2009) Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutrit Cancer 61:16–26CrossRefGoogle Scholar
  222. Maiti S, Bhutia SK, Mallick SK, Kumar A, Khadgi N, Maiti TK (2008) Antiproliferative and immunostimulatory protein fraction from edible mushrooms. Environ Toxicol Pharmacol 26:187–191PubMedCrossRefGoogle Scholar
  223. Maruyama H, Ikekawa T (2007) Immunomodulation and antitumor activity of a mushroom product, proflamin, isolated from Flammulina velutipes (W.Curt.:Fr.) Singer (Agaricomycetideae). Int J Med Mushr 9:109–122CrossRefGoogle Scholar
  224. Masuda Y, Ito K, Konishi M, Nanba H (2010) A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer. Cancer Immunol Immun 59:1531–1541Google Scholar
  225. Matsuda H, Akaki J, Nakamura S, Okazaki Y, Kojima H, Tamesada M, Yoshikawa M (2009) Apoptosis-inducing effects of sterols from the dried powder of cultured mycelium of Cordyceps sinensis. Chem Pharm Bull (Tokyo) 57:411–414CrossRefGoogle Scholar
  226. Matsui K, Kodama N, Nanba H (2001) Effects of Maitake (Grifola frondosa) D-fraction on the carcinoma angiogenesis. Cancer Lett 172:193–198PubMedCrossRefGoogle Scholar
  227. Mattila P, Konko K, Eurola M et al (2001) Contents of vitamins, mineral elements and some phenolic compounds in cultivated mushrooms. J Agric Food Chem 49:2343–2348PubMedCrossRefGoogle Scholar
  228. Mayell M (2001) Maitake extracts and their therapeutic potential. Altern Med Rev 6:48–60PubMedGoogle Scholar
  229. McMorris TC (1999) Discovery and development of sesquiterpenoid derived hydroxymethylacylfulvene: a new anticancer drug. Bioorg Med Chem 7:881–886PubMedCrossRefGoogle Scholar
  230. McMorris TC, Kelner MJ, Wang W, Yu J, Estes LA, Taetle R (1996) (Hydroxymethyl) acylfulvene: an illudin derivative with superior antitumor properties. J Nat Prod 59:896–899PubMedCrossRefGoogle Scholar
  231. McNeela EA, Mills KHG (2001) Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Rev 51:43–54PubMedCrossRefGoogle Scholar
  232. Miles PG, Chang ST (1997) Mushroom biology: concise basics and current developments. World Scientific Press, pp 161–175Google Scholar
  233. Misiek M, Williams J, Schmich K, Hüttel W, Merfort I, Salomon CE, Aldrich CC, Hoffmeister D (2009) Structure and cytotoxicity of arnamial and related fungal Sesquiterpene Aryl Esters. J Nat Prod 72:1888–1891PubMedCrossRefGoogle Scholar
  234. Mizuno T (1999a) Medicinal effects and utilization of Cordyceps (Fr.) Link (Ascomycetes) and Isaria Fr. (Mitosporic fungi) Chinese caterpillar fungi, “Tochukaso”. Int J Med Mushr 1:251–262Google Scholar
  235. Mizuno T (1999b) The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan. Int J Med Mushr 1:9–29Google Scholar
  236. Mizuno T (1999c) Bioactive substances in Hericium erinaceus (Bull., Fr.) Pers. (Yambushitake) and its medicinal utilization. Int J Med Mushr 2:105–119Google Scholar
  237. Mizuno T, Wasa T, Ito H, Suzuki C, Ukai N (1992) Antitumor-active polysaccharides isolated from the fruiting body of Hericium erinaceum, an edible and medicinal mushroom called yamabushitake or houtou. Biosci Biotechnol Biochem 56:347–348PubMedCrossRefGoogle Scholar
  238. Mizuno T, Kinoshita T, Zhuang C, Ito H, Mayuzumi Y (1995a) Antitumor-active heteroglycans from Niohshimeji mushroom, Tricholoma giganteum. Biosci Biotechnol Biochem 59:568–571PubMedCrossRefGoogle Scholar
  239. Mizuno T, Saito H, Nishitoba T, Kawagishi H (1995b) Antitumor active substances from mushrooms. Food Rev Int 11:23–61CrossRefGoogle Scholar
  240. Mizuno T, Yeohlui P, Kinoshita T, Zhuang C, Ito H, Mayuzumi Y (1996) Antitumor activity and chemical modification of polysaccharides from Niohshimeji mushroom, Tricholoma giganteum. Biosci Biotechnol Biochem 60:30–33PubMedCrossRefGoogle Scholar
  241. Mizuno T, Zhuang AK, Okamoto H, Kiho T, Ukai S, Leclerc S, Meijer L (1999) Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Pers.:Fr.) Pil. (Aphyllophoromycetideae). Int J Med Mushr 1:301–316Google Scholar
  242. Mo S, Wang S, Zhou G, Yang Y, Li Y, Chen X, Shi J (2004) Phelligridins C-F: cytotoxic pyrano[4,3-c][2]benzopyran-1,6-dione and furo[3,2-c]pyran-4-one derivatives from the fungus Phellinus igniarius. J Nat Prod 67:823–828PubMedCrossRefGoogle Scholar
  243. Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA (2007) Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol 7:701–724PubMedCrossRefGoogle Scholar
  244. Moullec G, Maïano C, Morin JS, Monthuy-Blanc J, Rosello L, Ninot G (2011) A very short visual analog form of the center for epidemiologic studies depression scale (CES-D) for the idiographic measurement of depression. J Affect Disord 128:220–234PubMedCrossRefGoogle Scholar
  245. Munz C, Steinman RM, Fujii S (2005) Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 202:203–207PubMedCrossRefGoogle Scholar
  246. Nakamura T, Akiyama Y, Matsugo S et al (2003) Purification of caffeic acid as an anti-oxidant from submerged culture mycelia of Phellinus linteus (Berk. et Curt.) Teng (Aphyllophoromycetideae). Int J Med Mushr 5:163–167CrossRefGoogle Scholar
  247. Nakamura N, Hirakawa A, Gao JJ, Kakuda H, Shiro M, Komatsu Y, Sheu CC et al (2004) Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line. J Nat Prod 67:46–48PubMedCrossRefGoogle Scholar
  248. Nanba H (1995) Results of non-controlled clinical study for various cancer patients using Maitake D-fraction. Explore 6:19–21Google Scholar
  249. Nanba H (1997a) Effect of Maitake D-fraction on cancer prevention. Ann N Y Acad Sci 833:204–207PubMedCrossRefGoogle Scholar
  250. Nanba H (1997b) Maitake D-fraction: healing and preventive potential for cancer. J Orthomol Med 12:43–49Google Scholar
  251. NCI (2006) National cancer institute. Biological therapies for cancer. Questions and answers. http://www.cancer.gov/cancertopics/factsheet/Therapy/biological
  252. NCI (2011) National cancer institute. Cancer topics http://www.cancer.gov/cancertopics/cancerlibrary/what-is-cancer
  253. Nemoto J, Ohno N, Saito K, Adachi Y, Yasomae T (1993) Expression of interleukin-1 family mRNAs by a highly branched β-(1→3)-D-glucan, OL-2. Biol Pharm Bull 16:1046–1050PubMedCrossRefGoogle Scholar
  254. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–477PubMedCrossRefGoogle Scholar
  255. Ng TB (1998) A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 30:1–4PubMedCrossRefGoogle Scholar
  256. Ng TB, Lam YW, Wang H (2003) Calcaelin, a new protein with translation-inhibiting, antiproliferative and antimitogenic activities from the mosaic puffball mushroom Calvatia caelata. Planta Med 69:212–217PubMedCrossRefGoogle Scholar
  257. Ninot G, Moullec G, Picot MC, Jaussent A, Desplan M, Brun JF, Mercier J, Hayot M, Prefaut C (2011) Outcomes of a one month hospital self-management program in moderate to severe COPD patients: a randomized controlled trial. Resp Med 105:377–385CrossRefGoogle Scholar
  258. Nomura M, Takahashi T, Uesugi A, Tanaka R, Kobayashi S (2008) Inotodiol, a lanostane triterpenoid, from Inonotus obliquus inhibits cell proliferation through caspase-3-dependent apoptosis. Anticancer Res 28:2691–2696PubMedGoogle Scholar
  259. Norikura T, Fujiwara K, Narita T, Yamaguchi S, Morinaga Y, Iwai K, Matsue H (2011) Anticancer activities of Thelephantin O and Vialinin A isolated from Thelephora aurantiotincta. J Agric Food Chem 59:6974–6979PubMedCrossRefGoogle Scholar
  260. Novak M, Vetvicka V (2009) Glucans as biological response modifiers. Endocr Metab Immune Disord-Drug Targets 9:67–75PubMedCrossRefGoogle Scholar
  261. Novak M, Rapkova R, Copikova J, Sarka E (2010) beta-glucan composition and structure: an evolution of views. Proceedings of the 6th international conference on polysaccharides-Glycoscience, 17–21Google Scholar
  262. Nowell PC (1986) Mechanisms of tumor progression. Cancer Res 46:2203–2207PubMedGoogle Scholar
  263. Nukata M, Hashimoto T, Yamamoto I, Iwasaki N, Tanaka M, Asakawa Y (2002) Neogrifolin derivatives possessing antioxidative activity from the mushroom Albatrellus ovinus. Phytochemistry 59:731–737PubMedCrossRefGoogle Scholar
  264. Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J (2007) Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother 56:905–911PubMedCrossRefGoogle Scholar
  265. Ohno N (2005) Structural diversity and physiological functions of β-glucans. Int J Med Mushr 7:167–174CrossRefGoogle Scholar
  266. Ohno N, Miura NN, Nakajima M, Yadomae T (2000) Anti-tumor 1,3-β-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 23:866–872PubMedCrossRefGoogle Scholar
  267. Ohno N, Nameda S, Harada T et al (2003) Immunomodulating activity of a S-glucan preparation, SCG, extracted from a culinary-medicinal mushroom, Sparassis crispa Wulf.: Fr. (Aphyllophoromycetidae), and application to cancer patients. Int J Med Mushr 5:359–368CrossRefGoogle Scholar
  268. Okazaki M, Adachi Y, Ohno N, Yadomae T (1995) Structure-activity relationship of β-(1→3)-D-glucans in the induction of cytokine production from macrophages in vitro. Biol Pharm Bull 18:1320–1327PubMedCrossRefGoogle Scholar
  269. Ooi VE, Liu F (1999) A review of pharmacology activities of mushroom polysaccharides. Int J Med Mushr 1:195–206Google Scholar
  270. Ooi VE, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharide–protein complexes. Curr Med Chem 7:715PubMedGoogle Scholar
  271. Oshiman K, Fujimiya Y, Ebina T, Suzuki I, Noji M (2002) Orally administered b-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice. Planta Med 68:610–614PubMedCrossRefGoogle Scholar
  272. Park YM, Won JH, Kim YH, Choi JW, Park HJ, Lee KT (2005) In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol 101:120–128PubMedCrossRefGoogle Scholar
  273. Parkinson DR (1995) Present status of biological response modifiers in cancer. Am J Med 99:54–56CrossRefGoogle Scholar
  274. Paterson RRM (2006) Ganoderma - A therapeutic fungal biofactory (Review). Phytochemistry 67:1985–2001Google Scholar
  275. Paterson RRM (2008) Cordyceps - A traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 69:1469–1495Google Scholar
  276. Peng Y, Zhang L, Zeng F, Kennedy JF (2005) Structure and antitumor activities of the water-soluble polysaccharides from Ganoderma tsugae mycelium. Carbohyd Polym 59:385–392CrossRefGoogle Scholar
  277. Petrova RD, Wasser SP, Mahajna J, Denchev CM, Nevo E (2005) Potential role of medicinal mushrooms in breast cancer treatment: current knowledge and future perspectives. Int J Med Mushr 7:141–155CrossRefGoogle Scholar
  278. Petrova RD, Mahajna J, Reznick AZ, Wasser SP, Denchev CM, Nevo E (2007) Fungal substances as modulators of NF-kappaB activation pathway. Mol Biol Rep 34(3):145–154PubMedCrossRefGoogle Scholar
  279. Petrova RD, Reznick AZ, Wasser SP, Denchev CM, Nevo E, Mahajna J (2008) Fungal metabolites modulating NF-κB activity: an approach to cancer therapy and chemoprevention. Oncol Rep 19:299–308PubMedGoogle Scholar
  280. Petrova R, Mahajna J, Wasser SP, Ruimi N, Denchev CM, Sussan S, Nevo E, Reznick AZ (2009) Marasmius oreades substances block NF-κB activity through interference with IKK activation pathway. Mol Biol Rep 36:737–744PubMedCrossRefGoogle Scholar
  281. Phillips KM, Ruggio DM, Horst RL, Minor B, Simon RR, Feeney MJ, Byrdwell WC, Haytowitz DB (2011) Vitamin D and sterol composition of 10 types of mushrooms from retail suppliers in the United States. J Agric Food Chem 59:7841–7853PubMedCrossRefGoogle Scholar
  282. Pierson AS, Gibbs P, Richards J, Russ P, Eckhardt SG, Gonzalez R (2002) A phase II study of Irofulven (MGI 114) in patients with stage IV melanoma. Invest New Drugs 20:357–362PubMedCrossRefGoogle Scholar
  283. Pöder R (2005) The Ice man’s fungi: facts and mysteries. Int J Med Mushr 7:357–359Google Scholar
  284. Pohleven J, Obermajer N, Sabotič J, Anžlovar S, Sepčić K, Kos J, Kralj B, Štrukelj B, Brzin J (2009) Purification, characterization and cloning of a ricin B-like lectin from mushroom Clitocybe nebularis with antiproliferative activity against human leukemic T cells. Biochim Biophys Acta 1790:173–181PubMedCrossRefGoogle Scholar
  285. Poindessous V, Koeppel F, Raymond E, Cvitkovic E, Waters SJ, Larsen AK (2003) Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells. Int J Oncol 23:1347–1355PubMedGoogle Scholar
  286. Pollack A (2009) Drug firms see fortune in treating cancer. Int Herald Tribune, pp 15–16Google Scholar
  287. Poucheret P, Fons F, Rapior S (2006) Biological and pharmacological activity of higher fungi: 20-year retrospective analysis. Cryptogam Mycol 27:311–333Google Scholar
  288. Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, Melcher AA (2008) The immune system—is it relevant to cancer development, progression and treatment? Clin Oncol 20:101–112CrossRefGoogle Scholar
  289. Price LA, Wenner CA, Sloper DT, Slaton JW, Novack JP (2010) Role for toll-like receptor 4 in TNF-alpha secretion by murine macrophages in response to polysaccharide Krestin, a Trametes versicolor mushroom extract. Fitoterapia 81:914–919PubMedCrossRefGoogle Scholar
  290. Rapior S, Fruchier A, Bessiere JM (1997) Volatile aroma constituents of Agaricus and Boletes. In: Pandalai SG (ed) Recent Research Developments in Phytochemistry, vol 1. Publ. Research Signpost, Trivandrum, pp 567–584Google Scholar
  291. Rapior S, Courtecuisse R, Francia C, Siroux Y (2000) Activités biologiques des champignons: recherches actuelles sur les facteurs de risque des maladies cardio-vasculaires. Annales de la Société d’Horticulture et d’Histoire Naturelle de l’Hérault 140:26–31Google Scholar
  292. Ratain MJ, Relling MV (2001) Gazing into a crystal ball—cancer therapy in the post-genomic era. Nat Med 7:283–285PubMedCrossRefGoogle Scholar
  293. Ren G, Zhao YP, Yang L, Fu CX (2008) Anti-proliferative effect of clitocine from the mushroom Leucopaxillus giganteus on human cervical cancer HeLa cells by inducing apoptosis. Cancer Lett 262:190–200PubMedCrossRefGoogle Scholar
  294. Reshetnikov SV, Wasser SP, Tan KK (2001) Higher Basidiomycota as a source of antitumor and immunostimulating polysaccharides. Int J Med Mushr 3:361–394Google Scholar
  295. Revillard JP (2002) Innate immunity. Eur J Dermatol 12:224–227PubMedGoogle Scholar
  296. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH (2005) Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmocol Exp Ther 314:1079–1086CrossRefGoogle Scholar
  297. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC (2004) Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 42:485–498PubMedCrossRefGoogle Scholar
  298. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, Williams DL, Gordon S, Tybulewicz VL, Brown GD, Reis e Sousa C (2005) Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22:507–517PubMedCrossRefGoogle Scholar
  299. Ruddon RW (2007) Cancer biology, 4th edn. Oxford University Press, USAGoogle Scholar
  300. Ruimi N, Petrova RD, Agbaria R, Sussan S, Wasser SP, Reznick AZ, Mahajna J (2010) Inhibition of TNFα-induced iNOS expression in HSV-tk transduced 9L glioblastoma cell lines by Marasmius oreades substances through NF-κB- and MAPK-dependent mechanisms. Mol Biol Rep 37(8):3801–3812PubMedCrossRefGoogle Scholar
  301. Russo A, Piovano M, Clericuzio M, Lombardo L, Tabasso S, Chamy MC, Vidari G, Cardile V, Vita-Finzi P, Garbarino JA (2007) Putrescine-1,4-dicinnamide from Pholiota spumosa (Basidiomycetes) inhibits cell growth of human prostate cancer cells. Phytomedicine 14:185–191PubMedCrossRefGoogle Scholar
  302. Russo A, Cardile V, Piovano M, Caggia S, Espinoza CL, Garbarino JA (2010) Pro-apoptotic activity of ergosterol peroxide and (22E)-ergosta-7,22-dien-5α-hydroxy-3,6-dione in human prostate cancer cells. Chem Biol Int 184:352–358CrossRefGoogle Scholar
  303. Sakagami H, Aoki T (1991) Induction of immunopotentiation activity by a protein bound polysaccharide, PSK. Anticancer Res 11:993–1000PubMedGoogle Scholar
  304. Sakagami Y, Mizoguchi Y, Shin T, Seki S, Kobayashi K, Morisawa S, Yamamoto S (1988) Effects of an anti-tumor polysaccharide, Schizophyllan, on interferon-γ and interleukin-2 production by peripheral blood mononuclear cells. Biochem Biophys Res Commun 155:650–655PubMedCrossRefGoogle Scholar
  305. Samorini G (2001) New data on the ethnomycology of psychoactive mushrooms. Int J Med Mushr 3:257–278Google Scholar
  306. Seiden MV, Gordon AN, Bodurka DC, Matulonis UA, Penson RT, Reed E, Alberts DS, Weems G (2006) A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. Gynecol Oncol 101:55–61PubMedCrossRefGoogle Scholar
  307. Selosse MA (2000) La symbiose. Structures et fonctions, rôle écologique et évolutif. Vuibert edn, Paris, France 154 pGoogle Scholar
  308. Shamtsyan M, Konusova V, Maksimova Y, Goloshchev A, Panchenko A, Simbirtsev A, Petrishchev N, Denisova N (2004) Immunomodulating and anti-tumor action of extracts of several mushrooms. J Biotechnol 113:77–83PubMedCrossRefGoogle Scholar
  309. Shang D, Li Y, Wang C et al (2011) A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol Rep 25:267–272PubMedGoogle Scholar
  310. Sheng L, Chen J, Li J, Zhang W (2011) An exopolysaccharide from cultivated Cordyceps sinensis and its effects on cytokine expressions of immunocytes. Appl Biochem Biotech 163:669–678CrossRefGoogle Scholar
  311. Sheu F, Chien PJ, Chien AL, Chen YF, Chin KL (2004) Isolation and characterization of an immunomodulatory protein (APP) from the Jew’s Ear mushroom Auricularia polytricha. Food Chem 87:593–600CrossRefGoogle Scholar
  312. Shimizu Y, Chen JT, Hirai Y, Nakayama K, Hamada T, Fujimoto I, Hasumi K (1989) Augmentation of immune responses of pelvic lymph node lymphocytes in cervical cancer patients by sizofiran. Nihon Sanka Fujinka Gakkai Zasshi 41:2013–2014PubMedGoogle Scholar
  313. Shin KH, Lim SS, Lee S, Lee YS, Jung SH, Cho SY (2003) Anti-tumour and immuno-stimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps spp. Phytother Res 17:830–833PubMedCrossRefGoogle Scholar
  314. Shu CH, Lin KJ, Wen BJ (2004) Effects of culture pH on the production of bioactive polysaccharides by Agaricus blazei in batch cultures. J Chem Technol Biotechnol 79:998–1002CrossRefGoogle Scholar
  315. Sliva D (2003) Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 2:358–364PubMedCrossRefGoogle Scholar
  316. Smith D, Ryan MJ (2009) Fungal sources for new drug discovery. In Access Science, ©McGraw-Hill Companies http://www.accessscience.com
  317. Soares R, Meireles M, Rocha A, Pirraco A, Obiol D, Alonso E, Joos G, Balogh G (2011) Maitake (D Fraction) mushroom extract induces apoptosis in breast cancer cells by BAK-1 gene activation source. J Med Food 14:563–572PubMedCrossRefGoogle Scholar
  318. Song G, Du Q (2010) Isolation of a polysaccharide with anticancer activity from Auricularia polytricha using high-speed countercurrent chromatography with an aqueous two-phase system. J Chromatogr A 1217:5930–5934PubMedCrossRefGoogle Scholar
  319. Song J, Rui-Ping P, Jing-Nan S, Gang H, Jin W, Jia-Guo Z (2007) Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis 12(7):1317–1326CrossRefGoogle Scholar
  320. Stewart BW, Kleihues P et al (2003) World cancer report. WHO International Agency for Research on Cancer (IARC) Press, LyonGoogle Scholar
  321. Strong K, Mathers C, Leeder S, Beaglehole R (2005) Preventing chronic diseases: how many lives can we save? Lancet 366:1578–1582PubMedCrossRefGoogle Scholar
  322. Sugiyama K, Kawagishi H, Tanaka A, Saeki S, Yoshida S, Sakamoto H, Ishiguro Y (1992) Isolation of plasma cholesterol-lowering components from ningyotake (Polyporus confluens) mushroom. J Nutr Sci Vitaminol 38:335–342PubMedCrossRefGoogle Scholar
  323. Surenjav U, Zhang L, Xu X, Zhang X, Zeng F (2006) Effects of molecular structure on antitumor activities of β-(1→3)-D-glucans from different Lentinus edodes. Carbohyd Polym 63:97–104CrossRefGoogle Scholar
  324. Takaku T, Kimura Y, Okuda H (2001) Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. Biochem Mol Action Nutr 131:1409–1413Google Scholar
  325. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Ann Rev Immunol 21:335–376CrossRefGoogle Scholar
  326. Tanaka K, Wakasugi J, Seki F, Koizumi Y, Tsuchiya S (1991) Effect of PSK on cell growth, chemotaxis and platelet aggregating activity of colon 26 cell line. Proceedings of the 50th Annual Japanese Cancer Association Meeting, 263Google Scholar
  327. Tang W, Gu T, Zhong JJ (2006a) Separation of targeted ganoderic acids from Ganoderma lucidum by reversed phase liquid chromatography with ultraviolet and mass spectrometry detections. Biochem Eng J 32:205–210CrossRefGoogle Scholar
  328. Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ (2006b) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80:205–211PubMedCrossRefGoogle Scholar
  329. Tergaonkar V (2006) Signaling networks in focus NF-κB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell B 38:1647–1653CrossRefGoogle Scholar
  330. Thetsrimuang C, Khammuang S, Chiablaem K, Srisomsap C, Sarnthima R (2011) Antioxidant properties and cytotoxicity of crude polysaccharides from Lentinus polychrous Lév. Food Chem 128:634–639CrossRefGoogle Scholar
  331. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD (1996) Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol 156:1235–1246PubMedGoogle Scholar
  332. Torisu M, Hayashi Y, Ishimitsu T, Fujimura T, Iwasaki K et al (1990) Significant prolongation of disease –free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 31:261–268PubMedCrossRefGoogle Scholar
  333. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133–146PubMedCrossRefGoogle Scholar
  334. Tsuji T, Du W, Nishioka T, Chen L, Yamamoto D, Chen CY (2010) Phellinus linteus extract sensitizes advanced prostate cancer cells to apoptosis in athymic nude mice. PLoS One 5(3):e9885PubMedCrossRefGoogle Scholar
  335. Umezawa K (2006) Inhibition of tumor growth by NF-KB inhibitors. Cancer Sci 97:990–995PubMedCrossRefGoogle Scholar
  336. Usui T, Iwasaki Y, Mizuno T, Tanaka M, Shinkai K, Arakawa M (1983) Isolation and characterization of anti-tumor active β-D-glucans from the fruit bodies of Ganoderma applanatum. Carbohyd Res 115:273–280CrossRefGoogle Scholar
  337. Uthaisangsook S, Day NK, Bahna SL, Good RA, Haraguchi S (2002) Innate immunity and its role against infections. Ann Allerg Asthma Immunol 88:253–264CrossRefGoogle Scholar
  338. Van de Putte K, Nuytinck J, Stubbe D, Le HT, Verbeken A (2011) Lactarius volemus sensu lato (Russulales) from northern Thailand: morphological and phylogenetic species concepts explored. Fungal Divers 45:99–130CrossRefGoogle Scholar
  339. Vaz JA, Heleno SA, Martins A, Almeida GM, Vasconcelos MH, Ferreira ICFR (2010) Wild mushrooms Clitocybe alexandri and Lepista inversa: in vitro antioxidant activity and growth inhibition of human tumour cell lines. Food Chem Toxicol 48:2881–2884PubMedCrossRefGoogle Scholar
  340. Vetvicka V, Dvorak B, Vetvickova J, Richter J, Krizan J, Sima P, Yvin JC (2007) Orally administered marine β-(1→3)-D-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 40:291–298PubMedCrossRefGoogle Scholar
  341. Vinogradov E, Petersen BO, Duusb JO, Wasserc S (2004) The structure of the glucuronoxylomannan produced by culinary medicinal yellow brain mushroom (Tremella mesenterica Ritz.:Fr., Heterobasidiomycetes) grown as one cell biomass in submerged culture. Carbohyd Res 339:1483–1489CrossRefGoogle Scholar
  342. Vos A, M’Rabet L, Stahl B, Boehm G, Garssen J (2007) Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. Crit Rev Immunol 27:97–140PubMedGoogle Scholar
  343. Wan JM, Sit WH, Louie JC (2008) Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. Int J Oncol 32:689–699PubMedGoogle Scholar
  344. Wang HX, Liu WK, Ng TB, Ooi VEC, Chang ST (1996) The immunomodulatory and antitumor activities of lectins from the mushroom Tricholoma mongolicum. Immunopharmacology 31:205–211PubMedCrossRefGoogle Scholar
  345. Wang H, Ng TB, Ooi VE (1998) Lectins from mushrooms. Mycol Res 102:897–906CrossRefGoogle Scholar
  346. Wang Y, Mo SY, Wang SJ, Li S, Yang YC, Shi JG (2005) A unique highly oxygenated Pyrano[4,3-c][2]benzopyran-1,6-dione derivative with antioxidant and cytotoxic activities from the fungus Phellinus igniarius. Org Lett 7(9):1675–1678PubMedCrossRefGoogle Scholar
  347. Wang Y, Shang XY, Wang SJ, Mo SY, Li S, Yang YC, Ye F, Shi JG, Lan H (2007) Structures, biogenesis, and biological activities of Pyrano[4,3-c]isochromen-4-one derivatives from the fungus Phellinus igniarius. J Nat Prod 70:296–299PubMedCrossRefGoogle Scholar
  348. Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biot 60:258–274CrossRefGoogle Scholar
  349. Wasser SP (2010) Shiitake. In: Encyclopedia of dietary supplements, 2nd edn. Informa Healthcare, New York, pp 719–726Google Scholar
  350. Wasser SP (2011) Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 89:1323–1332PubMedCrossRefGoogle Scholar
  351. Wasser SP, Akavia E (2008) Regulatory issues of mushrooms as functional foods and dietary supplements: safety and efficacy. In: Cheung PCK (ed) Mushrooms as functional foods. Wiley, New York, pp 199–221CrossRefGoogle Scholar
  352. Wasser SP, Weis AL (1999a) Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19:65–96PubMedGoogle Scholar
  353. Wasser SP, Weis AL (1999b) Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives. Int J Med Mushr 1:31–62Google Scholar
  354. Weng CJ, Yen GC (2010) The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis 27:361–369PubMedCrossRefGoogle Scholar
  355. WHO (2004) World Health Organization. The world health report 2004: changing history. GenevaGoogle Scholar
  356. WHO (2008) 2008–2013 Action plan for the global strategy for the prevention and control of non-communicable diseases. Prevent and control cardiovascular diseases, cancers, chronic respiratory diseases, diabetesGoogle Scholar
  357. WHO (2011) World Health Organization. www.who.int/mediacentre/events/annual/world_cancer_day
  358. Willment JA, Gordon S, Brown GD (2001) Characterization of the human β-glucan receptor and its alternatively spliced isoforms. J Biol Chem 276:43818–43823PubMedCrossRefGoogle Scholar
  359. Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S, Brown GD (2005) The human β-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol 35:1539–1547PubMedCrossRefGoogle Scholar
  360. Wong JH, Wang HX, Ng TB (2008) Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus. Appl Microbiol Biotechnol 81:669–674PubMedCrossRefGoogle Scholar
  361. Wong YY, Moon A, Duffin R, Barateig AB, Meijer HA, Clemens MJ, de Moor CH (2010a) Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem 285:2610–2621PubMedCrossRefGoogle Scholar
  362. Wong JH, Ng TB, Cheung RCF, Ye XJ, Wang HX, Lam SK et al (2010b) Proteins with antifungal properties and other medicinal applications from plants and mushrooms. Appl Microbiol Biotechnol 87:1221–1235PubMedCrossRefGoogle Scholar
  363. Woo MH, Peterson JK, Billups C, Liang H, Bjornsti MA, Houghton PJ (2005) Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models. Cancer Chemother Pharmacol 55:411–419PubMedCrossRefGoogle Scholar
  364. Woynarowski J, Napier C, Koester S (1997) Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF). Biochem Pharmacol l54:1181–1193CrossRefGoogle Scholar
  365. Wu JY, Zhang QX, Leung PH (2007) Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL/6 mice. Phytomedicine 14:43–49PubMedCrossRefGoogle Scholar
  366. Xia Y, Ross GD (1999) Generation of recombinant fragments of CD11b expressing the functional β-glucan-binding lectin site of CR3 (CD11b/CD18). J Immunol 162:7285–7293PubMedGoogle Scholar
  367. Xu K, Liang X, Gao F, Zhong J, Liu J (2010) Antimetastatic effect of ganoderic acid T in vitro through inhibition of cancer cell invasion. Process Biochem 45:1261–1267CrossRefGoogle Scholar
  368. Xu X, Yan H, Chen J, Zhang X (2011) Bioactive proteins from mushrooms. Biotechnol Adv 29:667–674PubMedCrossRefGoogle Scholar
  369. Yamashita K, Ougolkov AV, Nakazato H, Ito K, Ohashi Y, Kitakata H, Yasumoto K et al (2007) Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic β-catenin activation. Dis Colon Rectum 50:1169–1181PubMedCrossRefGoogle Scholar
  370. Yang L, Wang R, Liu J, Tong H, Deng Y, Li Q (2004) The effect of Polyporus umbellatus polysaccharide on the immunosuppression property of culture supernatant of S180 cells. Chinese J Cell Mol Immunol 20:234–237Google Scholar
  371. Yang Y, Ye L, Zhang JS, Liu YF, Tang QL (2009) Structural analysis of a bioactive polysaccharide, PISPI, from the medicinal mushroom Phellinus igniarius. Biosci Biotechnol Bichem 73:134–139CrossRefGoogle Scholar
  372. Yassin M, Wasser SP, Mahajna J (2008) Substances from the medicinal mushroom Daedalea gibbosa inhibit kinase activity of native and T315I mutated Bcr-Abl. Int J Oncol 32:1197–1204PubMedGoogle Scholar
  373. Ye M, Liu JK, Lu ZX, Zhao Y, Liu SF, Li LL, Tan M, Weng XX, Li W, Cao Y (2005) Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro. FEBS Lett 579(16):3437–3443PubMedCrossRefGoogle Scholar
  374. Ye M, Luo X, Li L, Shi Y, Tan M, Weng X, Li W, Liu J, Cao Y (2007) Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett 258(2):199–207PubMedCrossRefGoogle Scholar
  375. Ye LB, Zheng X, Zhang J, Tang Q, Yang Y, Wang X, Li J, Liu YF, Pan YJ (2011) Biochemical characterization of a proteoglycan complex from an edible mushroom Ganoderma lucidum fruiting bodies and its immunoregulatory activity. Food Res Int 44:367–372CrossRefGoogle Scholar
  376. Yeh CT, Rao YK, Yao CJ, Yeh CF, Li CH, Chuang SE, Luong JH et al (2009) Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett 285:73–79PubMedCrossRefGoogle Scholar
  377. Yeh CH, Chen HC, Yang JJ, Chuang WI, Sheu F (2010) Polysaccharides PS-G and protein LZ-8 from Reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. J Agric Food Chem 58:8535–8544PubMedCrossRefGoogle Scholar
  378. Ying J, Mao X, Ma Q, Zong Y, Wen H (1987) Icons of medicinal fungi from China (translated, Yuehan X). Science Press, BeijingGoogle Scholar
  379. Yoneda K, Ueta E, Yamamoto T, Osaki T (1991) Immunoregulatory effects of Sizofiran (SPG) on lymphocytes and polymorphonuclear leukocytes. Clin Exp Immunol 86:229–235PubMedCrossRefGoogle Scholar
  380. Yoshida I, Kiho T, Usui S, Sakushima M, Ukai S (1996) Polysaccharides in fungi. XXXVII. Immunomodulating activities of carboxymethylated derivatives of linear (1→3)-α-D-glucans extracted from the fruiting bodies of Agrocybe cylindracea and Amanita muscaria. Biol Pharm Bull 19:114–121PubMedCrossRefGoogle Scholar
  381. Yu Z, Ming G, Kaiping W, Zhixiang C, Liquan D, Jingyu L, Fang Z (2010) Structure, chain conformation and antitumor activity of a novel polysaccharide from Lentinus edodes. Fitoterapia 81:1163–1170PubMedCrossRefGoogle Scholar
  382. Yuen JWM, Gohel MDI (2005) Anti-cancer effects of Ganoderma lucidum: a review of scientific evidence. Nutrit Cancer 53:11–17CrossRefGoogle Scholar
  383. Zaidman BZ, Yassin M, Mahajna J, Wasser SP (2005) Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67:453–468PubMedCrossRefGoogle Scholar
  384. Zhang P, Zhang L, Cheng S (1999) Chemical structure and molecular weight of (1→3)-α-D-glucan from Lentinus edodes. Biosci Biotechnol Biochem 63:1197–1202CrossRefGoogle Scholar
  385. Zhang H, Morisaki T, Matsunaga H, Sato N, Uchiyama A, Hashizume K et al (2000) Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-β1 and MMPs. Clin Exp Metastasis 18:343–352PubMedGoogle Scholar
  386. Zhang L, Zhang X, Zhou Q, Zhang P, Zhang M, Li X (2001) Triple helix of β-glucan from Lentinus edodes in 0.5 M NaCl aqueous solution characterized by light scattering. Polym J 33:317–321CrossRefGoogle Scholar
  387. Zhang Y, Mills GL, Nair MG (2002) Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa. J Agric Food Chem 50:7581–7585PubMedCrossRefGoogle Scholar
  388. Zhang L, Li X, Xu X, Zeng F (2005) Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohyd Res 340:1515–1521CrossRefGoogle Scholar
  389. Zhang M, Cui SW, Cheung PCK, Wang Q (2007) Anti-tumor polysaccharides from mushrooms: a review on their isolation, structural characteristics and antitumor activity. Trends Food Sci Technol 18:4–19CrossRefGoogle Scholar
  390. Zhang W, Li J, Qiu S, Chen J, Zheng Y (2008) Effects of the exopolysaccharide fraction (EPSF) from a cultivated Cordyceps sinensis on immunocytes of H22 tumor bearing mice. Fitoterapia 79:168–173PubMedCrossRefGoogle Scholar
  391. Zhang GQ, Sun J, Wang HX, Ng TB (2009) A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa. Acta Biochim Pol 56:415–421PubMedGoogle Scholar
  392. Zhang G, Sun J, Wang H, Ng TB (2010) First isolation and characterization of a novel lectin with potent antitumor activity from a Russula mushroom. Phytomedicine 17:775–781PubMedCrossRefGoogle Scholar
  393. Zhang Y, Li S, Wang X, Zhang L, Cheung PCK (2011) Advances in lentinan: isolation, structure, chain conformation and bioactivities. Food Hydrocolloid 25:196–206CrossRefGoogle Scholar
  394. Zhao RI, Desjardin DE, Soytong K, Perry BA, Hyde KD (2010a) A monograph of Micropsalliota in Northern Thailand based on morphological and molecular data. Fungal Divers 45:33–79CrossRefGoogle Scholar
  395. Zhao YY, Chao X, Zhang Y, Lin RC, Sun WJ (2010b) Cytotoxic steroids from Polyporus umbellatus. Planta Medica 76(15):1755–1758PubMedCrossRefGoogle Scholar
  396. Zhao RL, Karunarathna SC, Raspé O, Parra LA, Guinberteau J, Moinard M, De Kesel A, Barroso G, Desjardin D, Courtecuisse R, Hyde KD, Guelly AK, Callac P (2011) Major clades in tropical Agaricus. Fungal Divers 51(1):279–296. doi:10.1007/s13225-011-0136-7 CrossRefGoogle Scholar
  397. Zheng W, Zhao Y, Zheng X, Liu Y, Pan S, Dai Y, Liu F (2011) Production of antioxidant and antitumor metabolites by submerged cultures of Inonotus obliquus cocultured with Phellinus punctatus. Appl Microbiol Biotechnol 89(1):157–167PubMedCrossRefGoogle Scholar
  398. Zhong JJ, Tang YJ (2004) Submerged cultivation of medicinal mushrooms for production of valuable bioactive metabolites. Adv Biochem Eng Biotechnol 87:25–59PubMedGoogle Scholar
  399. Zhong JJ, Xiao JH (2009) Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Adv Biochem Eng Biotechnol 113:79–150PubMedGoogle Scholar
  400. Zhou X, Lin JY, Zhao J, Sun X, Tang K (2005) Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med 35:559–574Google Scholar
  401. Zhou L, Shi P, Chen NH, Zhong JJ (2011) Ganoderic acid Me induces apoptosis through mitochondria dysfunctions in human colon carcinoma cells. Process Biochem 46:219–225CrossRefGoogle Scholar
  402. Zhu JS, Halpern GM, Jones K (1998a) The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis part 1. J Altern Complement Med 4:289–303PubMedCrossRefGoogle Scholar
  403. Zhu JS, Halpern GM, Jones K (1998b) The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis part II. J Altern Complement Med 4:429–457PubMedCrossRefGoogle Scholar
  404. Zhu T, Kim SH, Chen CY (2008) A medicinal mushroom: Phellinus linteus. Curr Med Chem 15:1330–1335PubMedCrossRefGoogle Scholar
  405. Zhuang C, Wasser SP (2004) Medicinal value of culinary-medicinal Maitake mushroom Grifola frondosa (Dicks.:Fr.) S.F.Gray (Aphyllophoromycetideae). Int J Med Mushr 6:287–313CrossRefGoogle Scholar
  406. Zhuang C, Mizuno T, Shimada A, Ito H, Suzuki C, Mayuzumi Y, Okamoto H, Ma Y, Li J (1993) Antitumor protein-containing polysaccharides from a Chinese mushroom Fengweigu or Houbitake, Pleurotus sajor-caju (Fr.) Sing. Biosci Biotechnol Biochem 57:901–906PubMedCrossRefGoogle Scholar
  407. Zjawiony JK (2004) Biologically active compounds from Aphyllophorales (Polypore) Fungi. J Nat Prod 67:300–310PubMedCrossRefGoogle Scholar

Copyright information

© The Mushroom Research Foundation 2012

Authors and Affiliations

  • Dilani D. De Silva
    • 1
    • 2
    • 3
  • Sylvie Rapior
    • 4
  • Françoise Fons
    • 4
  • Ali H. Bahkali
    • 5
  • Kevin D. Hyde
    • 1
    • 2
    • 5
  1. 1.Institute of Excellence in Fungal ResearchMae Fah Luang UniversityChiang RaiThailand
  2. 2.School of ScienceMae Fah Luang UniversityChiang RaiThailand
  3. 3.Department of Botany, Faculty of ScienceUniversity of PeradeniyaPeradeniyaSri Lanka
  4. 4.Faculty of PharmacyUniversity Montpellier 1, UMR 5175 CEFEMontpellier Cedex 5France
  5. 5.Botany and Microbiology Department, College of ScienceKing Saud UniversityRiyadhSaudi Arabia

Personalised recommendations